Merit Medical targets $4.33-$4.37 non-GAAP EPS in 2026 while adding Solo Pace for ~$45M
Earnings Call Insights: Merit Medical Systems (MMSI) Q3 2026
Management View
- "We reported total revenue of $416 million, up 8% year-over-year" and "third quarter total constant currency growth was driven by 9% organic growth" with "8% organic growth in sales of our foundational products and 11% organic growth in sales
Seeking Alpha's Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.